News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
ViaNautis Bio Signs Strategic Collaboration Agreement with Lilly to leverage its polyNaut® platform to develop novel products delivering genetic medicines
Tuesday, October 29, 2024ViaNautis Bio a groundbreaking biotechnology company at the forefront of delivering targeted genetic nanomedicines today announces a collaboration with Eli Lilly and Company Lilly Under the terms of the agreement ViaNautis will receive an initial upf...
QIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatment
Tuesday, October 29, 2024QIAGEN announced that the US Food and Drug Administration FDA has cleared the QIAstatDx Respiratory Panel Mini test for clinical use It is the third test to receive FDA clearance for use with QIAstatDx systems in The QIAstatDx Respiratory Panel Mini...
Introducing iQue®'s 2nd Edition High-Throughput Cytometry Handbook: Fast. Simple. Discover the Future of Cell Analysis!
Monday, October 28, 2024The life science group Sartorius has published its second edition HighThroughput Screening HTS by Cytometry handbook This handbook is designed to empower both new and seasoned flow cytometry users who are curious about the unique capabilities of HTS...
Bayer and Dewpoint Therapeutics sign Licensing Agreement for Heart Disease Program
Friday, October 25, 2024Bayer has entered into an exclusive licensing agreement with Dewpoint Therapeutics Inc for a heart disease program to treat dilated cardiomyopathy DCM patients who are characterized through carrying specific mutations This is the first option exercis...
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
Friday, October 25, 2024Lyell Immunopharma Inc announced today that it has entered into a definitive agreement to acquire ImmPACT Bio USA Inc ImmPACT a privatelyowned clinicalstage biotechnology company ImmPACTs lead program IMPT is a CDtargeting chimeric antigen receptor C...
PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes
Thursday, October 24, 2024PolTREG SA a clinicalstage biotechnology company developing cellular therapies for a wide range of autoimmune diseases has launched a placebocontrolled Phase clinical trial with PTG Treg cell therapy in presymptomatic type diabetes TD patients after...
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
Thursday, October 24, 2024Jasper Therapeutics Inc a clinical stage biotechnology company focused on development of briquilimab a novel antibody therapy targeting cKit CD to address mast cell driven diseases such as chronic spontaneous urticaria CSU chronic inducible urticaria...
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Wednesday, October 23, 2024Virax Biolabs Group Limited an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases today announced that it has entered into a distribution agreement with Europa Biosite to commercialize the co...
BioVersys Joins EU-Funded RespiriNTM Programme to Accelerate Development of Its Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
Tuesday, October 22, 2024BioVersys AG a multiasset clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious lifethreatening infections caused by multidrug resistant MDR bacteria announced today that it has join...
Virscio Extends Translational Expertise and Research Services to Molecular Biology
Tuesday, October 22, 2024Virscio a leading translational research organization today announced the launch of its new molecular biology division The addition of advanced molecular research capabilities to Virscios services portfolio enables highthroughput tissue sample proces...
